Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference27 articles.
1. Yatham LN, Kennedy SH, Parikh SV et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013;15: 1–44
2. Bowden CL, Singh V (2005) Valproate in bipolar disorder: 2000 onwards. Acta Psychiatr Scand 111:13–20
3. De Hert M, Correll CU, Bobes J et al (2011) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10(1):52–77
4. Chang HH, Yang YK, Gean PW, Huang HC, Chen PS, Lu RB (2010) The role of valproate in metabolic disturbances in bipolar disorder patients. J Affect Disord 124(3):319–323
5. Zuo S, Fries BE, Szafara K, Regal R (2015) Valproic acid as a potentiator of metabolic syndrome in institutionalized residents on concomitant antipsychotics: fat chance, or slim to none? PT 40(2):126–132
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献